{
  "query": "What new diabetes drugs are available in 2025?",
  "retrieved": [
    {
      "score": 1.05,
      "source_type": "blogs",
      "doc_id": "new_diabetes_drugs.md",
      "chunk_id": "new_diabetes_drugs.md::c0",
      "rerank_score": 8.919210433959961
    },
    {
      "score": 0.05,
      "source_type": "blogs",
      "doc_id": "new_diabetes_drugs.md",
      "chunk_id": "new_diabetes_drugs.md::c0",
      "rerank_score": 8.919210433959961
    },
    {
      "score": 1.079807147860338,
      "source_type": "docs",
      "doc_id": "diabetes_guidelines.md",
      "chunk_id": "diabetes_guidelines.md::c0",
      "rerank_score": -7.001124382019043
    },
    {
      "score": 0.6500000001752999,
      "source_type": "docs",
      "doc_id": "hypertension_guidelines.md",
      "chunk_id": "hypertension_guidelines.md::c2",
      "rerank_score": -7.023252487182617
    },
    {
      "score": 0.6500000001752999,
      "source_type": "docs",
      "doc_id": "diabetes_guidelines.md",
      "chunk_id": "diabetes_guidelines.md::c2",
      "rerank_score": -10.324777603149414
    }
  ],
  "contradictions": [
    [
      0,
      3,
      "contradiction"
    ],
    [
      1,
      3,
      "contradiction"
    ],
    [
      2,
      3,
      "contradiction"
    ]
  ],
  "resolution": {
    "decisions": [
      {
        "a": "new_diabetes_drugs.md::c0",
        "b": "hypertension_guidelines.md::c2",
        "preferred": "hypertension_guidelines.md::c2",
        "discarded": "new_diabetes_drugs.md::c0",
        "reason": "Preferred docs over blogs"
      },
      {
        "a": "new_diabetes_drugs.md::c0",
        "b": "hypertension_guidelines.md::c2",
        "preferred": "hypertension_guidelines.md::c2",
        "discarded": "new_diabetes_drugs.md::c0",
        "reason": "Preferred docs over blogs"
      },
      {
        "a": "diabetes_guidelines.md::c0",
        "b": "hypertension_guidelines.md::c2",
        "preferred": "diabetes_guidelines.md::c0",
        "discarded": "hypertension_guidelines.md::c2",
        "reason": "Preferred docs over docs"
      }
    ]
  },
  "answer": {
    "response": "Based on clinical guidelines and community knowledge: # New Diabetes Drugs in 2025\nRecent studies highlight GLP-1 receptor agonists (like Semaglutide) not only lower blood sugar but also promote weight loss.\nThey are considered after Metformin if HbA1c remains above goal. # New Diabetes Drugs in 2025\nRecent studies highlight GLP-1 receptor agonists (like Semaglutide) not only lower blood sugar but also promote weight loss.\nThey are considered after Metformin if HbA1c remains above goal. # Type 2 Diabetes Guidelines\nFirst-line treatment for type 2 diabetes is **Metformin**, unless contraindicated.\n\n⚠️ Disclaimer: This is not medical advice. Please consult a healthcare professional.",
    "citations": [
      {
        "source": "blogs",
        "doc": "new_diabetes_drugs.md",
        "chunk": "new_diabetes_drugs.md::c0"
      },
      {
        "source": "blogs",
        "doc": "new_diabetes_drugs.md",
        "chunk": "new_diabetes_drugs.md::c0"
      },
      {
        "source": "docs",
        "doc": "diabetes_guidelines.md",
        "chunk": "diabetes_guidelines.md::c0"
      }
    ]
  }
}